Advertisement

Elotuzumab in Previously Treated Multiple Myeloma

On November 30, 2015, elotuzu­mab (Empliciti) was approved for use in combination with lenalidomide (Revlimid) and dexamethasone for the treatment of patients with multiple myeloma who have received one to three prior therapies. 

 The ASCO Post

click me